Clinical trial
A Phase IIa Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Bimatoprost in the Treatment of Migraine
NCT03419715 is registered in ClinicalTrials.gov with Manistee Partners as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIa Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Bimatoprost in the Treatment of Migraine
- Lead sponsor
- Manistee Partners
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 5, 2018
- Completion date
- June 30, 2019
- Enrollment
- 70 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.